Bangkok (VNA) – Thailand’s Food and DrugAdministration (FDA) has approved the use of Favipiravir tablets manufacturedby the Government Pharmaceutical Organisation (GPO) in Thailand for thetreatment of COVID-19 to meet rising demand in the country.
GPO expert Nantakarn Suwanpitakkun said made-in-Thailand Favipiravirtablets cost only half the prices of their imported equivalent, while theirquality is the same.
Thailand needs about 300,000 Favipiravir tablets each day, orabout 9 million a month. Earlier, GPO had imported an additional 5.5 milliontablets for treatment after the third wave of COVID-19 starting in early Aprilquickly spread to many countries.
In recent days, the number of daily new COVID-19 cases inThailand continued to surge to new records. On July 25 morning, the healthministry announced 15,335 cases in the past 24 hours, raising the nationaltally to 497,302. The same day, the pandemic claimed 129 more lives, bringingthe total fatalities to 4,059.
Thailand has so far administered 15.3 million doses ofCOVID-19 vaccine./.